Skip to main content

Table 2 Methylation status and overall survival in primary breast cancer patients using Cox proportional hazard model

From: Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

  Patients Φ (%) Deaths HR 95%CI* P
Cohort 1       
UM 30 (44.1) 14 1.0(ref)   
M 38 (55.9) 12 0.53 0.23 to 1.23 0.14
Cohort 2       
UM 50 (53.8) 21 1.0(ref)   
M 43 (46.2) 28 0.50 0.23 to 1.08 0.08
  1. Φ Cohort 1 (n = 68) and Cohort 2 (n = 93).
  2. * Adjusted for age, period of diagnosis, ER, PR and p53 status. HR, hazard ratio; UM, unmethylated; M, methylated.